Sakar Healthcare
Sakar Healthcare Share Price Chart
Sakar Healthcare last traded at ₹981.20 (2026-10-13). Over the past month the stock moved -12.2%, three months the stock moved +24.8%, year the stock moved +185.5%. Its closing range over 52 weeks is ₹351.50 – ₹1,179.80, with the latest close 16.8% below the high.
Closing prices up to 2026-10-13.
About Sakar Healthcare
Incorporated in 2004, Sakar Healthcare Ltd is in the business of manufacturing Research & Development of Pharmaceutical products[1]
Business Overview:[1][2][3] SHL, certified by ISO 9001:2015 (BVQI), WHO-GMP, cGMP, and the National Drug Authority, provides comprehensive healthcare and pharmaceutical products. Operating in over 50 countries with 292 registered products and 210 more under registration, SHL partners with 70+ overseas distributors. The company also engages in contract manufacturing for leading domestic brands and direct sales in both domestic and export markets.
Fundamentals
Quarterly Results
In the latest quarter (Jun 2026), Sakar Healthcare reported sales of ₹73.00 crore (+37.7%) and net profit of ₹10.00 crore (+100.0%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 73.00 | 21.00 | 29.00 | 10.00 | 4.62 |
| Mar 2026 | 71.00 | 26.00 | 37.00 | 11.00 | 4.95 |
| Dec 2025 | 70.00 | 19.00 | 26.00 | 10.00 | 4.61 |
| Sep 2025 | 58.00 | 11.00 | 20.00 | 5.00 | 2.04 |
| Jun 2025 | 53.00 | 13.00 | 24.00 | 5.00 | 2.10 |
| Mar 2025 | 50.00 | 16.00 | 31.00 | 6.00 | 2.62 |
| Dec 2024 | 43.00 | 12.00 | 27.00 | 5.00 | 2.06 |
| Sep 2024 | 43.00 | 12.00 | 27.00 | 5.00 | 2.21 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +26.5% | +16.2% | +16.3% | +29.3% | +34.9% | +62.8% | +42.0% | +37.7% |
| Operating profit growth | +33.3% | +33.3% | +45.5% | +18.2% | -8.3% | +58.3% | +62.5% | +61.5% |
| Net profit growth | +25.0% | +150.0% | +100.0% | +150.0% | +0.0% | +100.0% | +83.3% | +100.0% |
| EPS growth | +30.0% | +116.8% | +83.2% | +89.2% | -7.7% | +123.8% | +88.9% | +120.0% |
| OPM % | 27.0% | 27.0% | 31.0% | 24.0% | 20.0% | 26.0% | 37.0% | 29.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Annual Financials
In the latest year (Mar 2026), Sakar Healthcare reported sales of ₹252.00 crore (+41.6%) and net profit of ₹30.00 crore (+66.7%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 252.00 | 69.00 | 27.00 | 30.00 | 13.70 |
| Mar 2025 | 178.00 | 50.00 | 28.00 | 18.00 | 7.97 |
| Mar 2024 | 153.00 | 38.00 | 25.00 | 12.00 | 5.37 |
| Mar 2023 | 133.00 | 33.00 | 25.00 | 13.00 | 6.70 |
| Mar 2022 | 128.00 | 29.00 | 23.00 | 15.00 | 8.90 |
| Mar 2021 | 95.00 | 23.00 | 24.00 | 11.00 | 6.84 |
| Mar 2020 | 83.00 | 20.00 | 24.00 | 10.00 | 6.43 |
| Mar 2019 | 68.00 | 17.00 | 25.00 | 7.00 | 4.47 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +28.3% | +22.1% | +14.5% | +34.7% | +3.9% | +15.0% | +16.3% | +41.6% |
| Operating profit growth | +30.8% | +17.6% | +15.0% | +26.1% | +13.8% | +15.2% | +31.6% | +38.0% |
| Net profit growth | +75.0% | +42.9% | +10.0% | +36.4% | -13.3% | -7.7% | +50.0% | +66.7% |
| EPS growth | +43.3% | +43.8% | +6.4% | +30.1% | -24.7% | -19.9% | +48.4% | +71.9% |
| OPM % | 25.0% | 24.0% | 24.0% | 23.0% | 25.0% | 25.0% | 28.0% | 27.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Shareholding
AI Analysis
No AI analysis generated yet for Sakar Healthcare.
Get Free AI Stock Analysis FREE →Latest News
-
Sakar Healthcare Bags 14 Oncology Approvals in EU, UK
-
Sakar Healthcare PAT rises 120% in Q1FY27 as oncology pipeline expands - scanx.trade
-
Sakar Healthcare consolidated net profit rises 120.13% in the June 2026 quarter - Business Standard
-
Cobra India acquires 2.05% stake in Sakar Healthcare via open market - scanx.trade
-
Sakar Healthcare jumps after Gautam Baid-founded fund buys stake via bulk deal - Business Standard
-
Stellar Wealth Partners India Fund acquires 0.87% stake in Sakar Healthcare, Zerodha Broking buys Rs 93 crore worth of Nazara Tech shares - Moneycontrol.com
-
Stellar Wealth Partners India Fund acquires 0.87% stake in Sakar Healthcare, Zerodha Broking buys Rs 93 crore worth of Nazara Tech shares - Moneycontrol.com
-
Stellar Wealth Partners India Fund acquires 0.87% stake in Sakar Healthcare, Zerodha Broking buys Rs 93 crore worth of Nazara Tech shares - Moneycontrol.com
-
Stellar Wealth Partners India Fund acquires 0.87% stake in Sakar Healthcare, Zerodha Broking buys Rs 93 crore worth of Nazara Tech shares - Moneycontrol.com
Frequently Asked Questions
What is Sakar Healthcare's current stock price?
Sakar Healthcare shares were last quoted at ₹981.20 (-3.0% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
What is the P/E ratio of Sakar Healthcare?
Sakar Healthcare has a price-to-earnings (P/E) ratio of 70.03 and a price-to-book (P/B) ratio of 7.55. The industry P/E is 101.02.
What is the 52-week high and low of Sakar Healthcare?
The 52-week high of Sakar Healthcare is ₹1,229.85 and the 52-week low is ₹345.50.
What is the market cap of Sakar Healthcare?
The market capitalisation of Sakar Healthcare is about ₹2,527.26 crore.
How did Sakar Healthcare perform in its latest quarterly results?
In the latest quarter (Jun 2026), Sakar Healthcare reported sales of ₹73.00 crore (+37.7%) and net profit of ₹10.00 crore (+100.0%), compared with the same quarter last year.
Is Sakar Healthcare a good stock to buy?
This page is for information and is not investment advice. As per the data shown here, Sakar Healthcare has a 3-year ROE of 7.00%, 3-year profit growth of 34.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
What is the promoter holding in Sakar Healthcare?
Promoters hold about 52.52% of Sakar Healthcare.
Which sector does Sakar Healthcare belong to?
Sakar Healthcare belongs to the Pharmaceuticals & Drugs sector.